Log in or Sign up for Free to view tailored content for your specialty!
Liver/Biliary Disorders News
FDA approves Cuvrior for treatment of adults with stable Wilson’s disease
Orphalan announced FDA approval of Cuvrior for the treatment of adults with stable Wilson’s disease who are de-coppered and tolerant to penicillamine, according to a company press release.
CDC: Adenovirus should be considered in diagnosis of acute hepatitis in children
Several cases of acute, severe hepatitis in children in Alabama provided additional evidence in support of a possible link between this illness and adenovirus, according to a report published in Morbidity and Mortality Weekly Report.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Mediterranean diet for NAFLD goes beyond just following a food list
The Mediterranean diet, which may help reverse the early stages of nonalcoholic fatty liver disease, requires patience, practice and the development of new life skills, according to one expert dietician.
Q&A: ‘The search for answers continues,’ expert says about hepatitis outbreak in children
As the WHO continues its investigation into an outbreak of severe, acute hepatitis of unknown origin in children aged 1 month to 16 years, more questions than answers remain.
Mystery outbreak of severe hepatitis in children prompts worldwide surveillance
The WHO has reported at least 169 cases of severe, acute hepatitis in children aged 1 month to 16 years from a dozen countries worldwide, according to a statement from the organization.
Q&A: Drinking pickle juice may reduce muscle cramp severity in patients with cirrhosis
Pickle juice consumed at the onset of muscle cramps improved severity but did not prevent future cramps in patients with cirrhosis, according to research published in the American Journal of Gastroenterology.
AHA: Addressing ‘undiagnosed’ NAFLD could mitigate CVD risk
Nonalcoholic fatty liver disease remains widely undiagnosed, yet early identification and treatment could mitigate long-term risk for CVD, according to a new American Heart Association scientific statement.
Alcohol-associated liver disease mortality on rise, surged during pandemic
Alcohol-associated liver disease mortality rates increased each year from 2017 to 2020 and accelerated during the COVID-19 pandemic, according to data published in Clinical Gastroenterology and Hepatology.
Clear, evidence-based guidelines needed for NAFLD in type 2 diabetes
New findings published in Diabetic Medicine highlighted the urgent need for clear, evidence-based guidelines for managing nonalcoholic fatty liver disease in individuals with type 2 diabetes.
VIDEO: New interventions may soon treat alcohol-related hepatitis, expert says
In this Healio video exclusive, Steven L. Flamm, MD, chief of the hepatology program at Northwestern Feinberg School of Medicine, discusses the rise in alcohol-related hepatitis during COVID-19, as well as promising new treatment options.